Parallelly, a comprehensive evaluation of RAG1/2 and AID expression signatures in correlation with CNA profiles allowed for further characterization of mutational processes behind selected ALL subtypes associated with poor prognosis. The gene discussed is AICDA; the disease is acute lymphoblastic leukemia.